Yong Yang
9PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.Jing Yang, Qiu-Zi Zhong, Li-Ting Qian
|Oct 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma.Fei Luo, Qiu-Zi Zhong, Xin Liu
|Jan 05, 2024
Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survival.Wan-Ru Zhang, Xin Liu, Qiu-Zi Zhong
|Feb 11, 2023
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma-an exploration of surrogate endpoint.Zewei Zhang, Chunxia Xie, Tiantian Gao
|Oct 01, 2022
The value of routine bone marrow examination in patients with extranodal NK/T-cell lymphoma staged with PET/CT.Yong Yang, Ji-Jin Wang, Rui-Zhi Zhao
|Apr 18, 2022
Progression-free survival at 3 years is a reliable surrogate for 5-year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma.Yu-Xian Yang, Yu-Zhen Zheng, Tian-Tian Gao
Pageof 2
Frequent Collaborators
3 joint publications
Ye-Xiong Li
2 joint publications
Lei Zhao
2 joint publications
Qiu-Zi Zhong
1 joint publications
Bin Liang
1 joint publications
Na Yang
1 joint publications
Guosheng He
1 joint publications
Peng Huang
1 joint publications
Fei Luo
1 joint publications
Xiao-Rong Hou
1 joint publications
Xi-Mei Zhang
